Details for New Drug Application (NDA): 020180
✉ Email this page to a colleague
The generic ingredient in PROSCAR is finasteride. There are fourteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the finasteride profile page.
Summary for 020180
Tradename: | PROSCAR |
Applicant: | Merck |
Ingredient: | finasteride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 020180
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Jun 19, 1992 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 020180
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merck | PROSCAR | finasteride | TABLET;ORAL | 020180-001 | Jun 19, 1992 | See Plans and Pricing | See Plans and Pricing |
Merck | PROSCAR | finasteride | TABLET;ORAL | 020180-001 | Jun 19, 1992 | See Plans and Pricing | See Plans and Pricing |
Merck | PROSCAR | finasteride | TABLET;ORAL | 020180-001 | Jun 19, 1992 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription